Explore
Validate
Learn
Western blot
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-30206 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Coronin 2A Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant protein fragment
- Description
- Recommended positive controls: Raji. Predicted reactivity: Mouse (89%), Rat (90%), Bovine (90%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Submitted references Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response.
Martins-de-Souza D, Solari FA, Guest PC, Zahedi RP, Steiner J
NPJ schizophrenia 2015;1:15050
NPJ schizophrenia 2015;1:15050
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 ( a ) Biological processes represented by all 985 plasma proteins identified through the shotgun mass spectrometry profiling approach; ( b ) western blot validation of the mass spectrometry findings for coronin-2A, which showed increased levels in responders and decreased levels in non-responders; ( c ) Biological pathways affected by antipsychotics in responders (blue bars) and non-responders (red bars); ( d ) Percentage of proteins increased in responders (blue), decreased in responders (red), increased in non-responders (green) and decreased in non-responders (purple) in the same biological pathways shown in part ( c ). For ( c and d ) the y axis represents the percentage of differentially expressed proteins associated to those processes and a star indicates significant differences of the protein constituents ( c ) or directional changes ( d ) within a pathway.
